SCHEMBL20037457

SCHEMBL20037457

CC(C)c1ccc(CN2CCNCC2)nn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 9/20 0.43
▸ SIGMAR1 Q99720 1/20 0.41
▸ KDM5C P41229 1/20 0.40
▸ KDM4C Q9H3R0 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CHRM2 P08172 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ CCR2 P41597 1/20 0.38
▸ CXCL12 P48061 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291567 0.79 CXCR4 (0.46) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL20037955 0.76 CXCR4 (0.46) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL18291540 0.76 CXCR4 (0.46) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL20249218 0.75 CXCR4 (0.43) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL20803980 0.74 CXCR4 (0.42) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL20203429 0.74 CXCR4 (0.47) CXCR4SIGMAR1CHRM2MEN1CHRM1
SCHEMBL20203428 0.72 BPTF (0.57) TDP1HRH3ALDH1A1CYP1A2SLC6A4
SCHEMBL19203825 0.70 CXCR4 (0.44) CXCR4SIGMAR1KDM5CKDM4CLMNA
SCHEMBL18291648 0.70 CXCR4 (0.57) CXCR4SIGMAR1CHRM2MEN1CHRM1
SCHEMBL12028965 0.70 CXCR4 (0.41) CXCR4SIGMAR1KDM5CKDM4CLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback